Doing Well While Doing Good

Investor Relations

Guided Therapeutics, Inc. (OTC: QB GTHP) has developed a rapid and painless testing platform for the early detection of disease that leads to cancer-based on its patented biophotonic technology. GTI has been headquartered outside of Atlanta, GA since it was founded, maintaining world-class scientific facilities in the U.S. and at our partner’s facilities in Europe.

Since our founding, our team has designed, manufactured, and marketed innovative, non-invasive medical device products to healthcare professionals around the world. Our current product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In several clinical studies involving thousands of women, it has proven to detect cervical cancer at its earliest stage, when it is most treatable.

Groundwork Laid for Near Term Financial Growth


R&D funded by five consecutive competitive NCI grants


Product Development Completed and Commercially Available


Extensive patent portfolio covering both method and design inventions


Product sold via country specific distributors


Product line consists of hardware, proprietary software, and single-use disposable


International Regulatory Approvals: CE marked, ISO 13485:2016, and other country specific approvals

Investor Resources

Our investors documents are just one click away. Select a button below and the document will open.

Compensation Committee Charter

Keep up with the latest news from Guided Therapeutics.